Tuesday 30 June

CRISPR IP Considerations

When and where

Date and time

Start: Tuesday 30 June 2020, 12:30 PM

End: Tuesday 30 June 2020, 01:30 PM

Event Overview

Ever wondered why CRISPR is at the forefront of multiple patent interferences in the US and contentious proceedings before the EPO? This webinar will explain for those not familiar with the technology why there is such interest, will give a short overview of the IP battles aimed at all patent attorneys and, for those working in life sciences, will finish with some considerations when drafting in this field.


Fellows, Students


Cath Coombes, Murgitroyd

Cath Coombes, Murgitroyd

Cath Coombes is a Director, Patents at Murgitroyd. She has a particular interest in CRISPR technology having spent over a decade being involved in oppositions and prosecution of patent applications in this field. Her experience encompasses early patents in this field manipulating CRISPR as an innate bacterial immune system to gene editing applications, diagnostics and antimicrobial applications. She has written numerous articles on CRISPR and provides comments on CRISPR IP for various journals, such as Nature, Science and The Scientist.

The event has been added to your basket:

CRISPR IP Considerations

Proceed to basket

Shopping Basket

No products in the cart.

Are you a CIPA member?

Sign in to your account to register for the event

Forgotten password?

If you are not yet registered or a member of CIPA, please register here

Skip to content